Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
This trial was designed to investigate whether the survival outcome, response rate and safety
of hepatic arterial infusion of oxaliplatin, fluorouracil/leucovorin regimens for patients
with Barcelona-Clinic Liver Cancer (BCLC)-C stage hepatocellular carcinoma was superior than
those of the standard treatment with sorafenib or not.